Medpace is a contract research organization that provides research based drug and medical device development services...
Read moreMedpace is a contract research organization that provides research based drug and medical device development services...
Read moreChairman & CEO
August J. Troendle
Annual Revenue
$1.4B
Medpace's revenue is the ranked 9th among it's top 10 competitors. The top 10 competitors average 3.7B. Over the last four quarters, Medpace's revenue has grown by 24.4%. Specifically, in Q3 2022's revenue was $383.7M; in Q2 2022, it was $351.2M; in Q1 2022, it was $330.9M; in Q4 2021, Medpace's revenue was $308.6M.